Part Two: Cannabis Legalization and Governing in the Cannabis Industry

Rarely in history do we get an opportunity to see a completely new industry emerge before our eyes, in real time, and quickly!

The legalization of medical and subsequently retail cannabis products, and the corresponding rapid establishment of production, extraction, distribution and retailing operations enable us to explore the dynamics from inside this industry. This speaker series will explore the lessons learned so far, and what continues to be learned by boards and executives leading new structures, raising capital, developing business and networks within an evolving regulatory system.

This second of a two-part series will focus on the insights gained in the boardroom related to cannabis legalization and the many issues experienced within boardrooms and by executive teams.


Trevor Fencott is an experienced c-suite executive and entrepreneur with more than 20 years of experience in building, scaling and successfully monetizing companies. He is the co-founder, CEO and a director of Fire & Flower Holding Corp. a leading regulated retailer of cannabis in Canada.

Prior to Fire & Flower, Mr. Fencott was co-founder, CLO and a director of Mettrum Health Corp., growing the business to Canada’s second largest licensed cannabis producer before its successful sale to Canopy Growth for $430MM in 2017. Prior to the regulated cannabis industry, Mr. Fencott was co-founder, director and a c-suite executive of a number of successful software companies. He also serves on the board of Push Capital, a private equity company focused on early-stage companies in the technology and cannabis sectors.

Michael Singer was appointed Executive Chairman at Aurora in March 2019, previously was the Company’s Chairman of the Board since joining as an independent director in May 2016. Mr. Singer is an accomplished pharmaceutical and cannabis industry executive, who has held a number of executive management and corporate governance roles. From 2015 to 2018 Mr. Singer was the Chief Financial Officer of NASDAQ listed Clementia Pharmaceuticals Inc., a Montreal based clinical stage biopharmaceutical company. From May 2014 until June 2015, Mr. Singer was Chief Financial Officer of Bedrocan Cannabis Corp, one of the first Canadian cannabis companies to receive a license.

Mr. Singer has also held several independent director and committee roles in Canadian public health care companies. Mr.Singer is a Chartered Professional Accountant (CPA, CGA), holds a Graduate Diploma in Public Accounting from McGill University and a Bachelor of Commerce from Concordia University.


May 28, 2019

Registration:  3:30 pm – 4:00 pm
Session: 4:00 pm – 5:15 pm
Reception: 5:30 pm – 7:00 pm

Location | Lieu:

Braemer Room
Royal Glenora
11160 River Valley Road NW
Edmonton, Alberta

CEUs | CFCs:


Price | Prix :

Member: $65 +tax
Non-member: $95 +tax

Organizer | Organisateur:

Edmonton Chapter

Contact | Contacter:

Joline Veitch

Please be advised that photographs may be taken at this event, and photographs may be published in various media, including print and online, without further notice. If you have questions about the use of event photographs by the ICD,  please contact
The Institute of Corporate Directors (ICD), its partners and event attendees may also post discussions, Tweets and pictures on various social media channels. We encourage event participants to engage in discussions via Twitter @ICDCanada and to include the hashtag #goodgovernance. The ICD also regularly hosts events that operate under a modified Chatham House Rule – that is that contributions may be published but are not to be attributed to any individual speaker. Invitations to such events will explicitly state that the event is operating under such restrictions.